Susquehanna International Group, LLP Evelo Biosciences, Inc. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	BUY	$0.17 - $1.57 $6,467 - $59,730	38,045 Added 26.05%	184,104 $33,000
Q4 2022 Feb 14, 2023	BUY	$1.44 - $48.2 $184,443 - $6.17 Million	128,086 Added 712.66%	146,059 $235,000
Q3 2022 Nov 14, 2022	BUY	$1.86 - $41.8 $33,429 - $751,271	17,973 New	17,973 $38,000
Q1 2022 May 16, 2022	BUY	$2.66 - $6.63 $447,627 - $1.12 Million	168,281 Added 488.15%	202,754 $687,000
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $334,732 - $641,197	34,473 New	34,473 $369,000
Q4 2020 Feb 16, 2021	SELL	$3.91 - $12.28 $46,364 - $145,616	-11,858 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.81 - $5.73 $45,178 - $67,946	11,858 New	11,858 $62,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.